ANVS
Price
$1.22
Change
-$0.04 (-3.17%)
Updated
Apr 17 closing price
Capitalization
23.77M
19 days until earnings call
IGC
Price
$0.28
Change
-$0.01 (-3.45%)
Updated
Apr 17 closing price
Capitalization
22.61M
60 days until earnings call
Ad is loading...

ANVS vs IGC

Header iconANVS vs IGC Comparison
Open Charts ANVS vs IGCBanner chart's image
Annovis Bio
Price$1.22
Change-$0.04 (-3.17%)
Volume$73.59K
Capitalization23.77M
IGC Pharma
Price$0.28
Change-$0.01 (-3.45%)
Volume$70.27K
Capitalization22.61M
ANVS vs IGC Comparison Chart
Loading...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANVS vs. IGC commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVS is a Hold and IGC is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (ANVS: $1.22 vs. IGC: $0.28)
Brand notoriety: ANVS and IGC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANVS: 22% vs. IGC: 21%
Market capitalization -- ANVS: $23.77M vs. IGC: $22.61M
ANVS [@Biotechnology] is valued at $23.77M. IGC’s [@Biotechnology] market capitalization is $22.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANVS’s FA Score shows that 0 FA rating(s) are green whileIGC’s FA Score has 0 green FA rating(s).

  • ANVS’s FA Score: 0 green, 5 red.
  • IGC’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANVS and IGC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANVS’s TA Score shows that 5 TA indicator(s) are bullish while IGC’s TA Score has 4 bullish TA indicator(s).

  • ANVS’s TA Score: 5 bullish, 2 bearish.
  • IGC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ANVS is a better buy in the short-term than IGC.

Price Growth

ANVS (@Biotechnology) experienced а -4.69% price change this week, while IGC (@Biotechnology) price change was +5.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was -13.21%, and the average quarterly price growth was -24.46%.

Reported Earning Dates

ANVS is expected to report earnings on Aug 13, 2025.

IGC is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANVS($23.8M) has a higher market cap than IGC($22.6M). IGC YTD gains are higher at: -15.565 vs. ANVS (-75.746). IGC has higher annual earnings (EBITDA): -7.58M vs. ANVS (-30.4M). ANVS has more cash in the bank: 12.6M vs. IGC (470K). IGC has higher revenues than ANVS: IGC (1.24M) vs ANVS (0).
ANVSIGCANVS / IGC
Capitalization23.8M22.6M105%
EBITDA-30.4M-7.58M401%
Gain YTD-75.746-15.565487%
P/E RatioN/AN/A-
Revenue01.24M-
Total Cash12.6M470K2,681%
Total DebtN/A270K-
FUNDAMENTALS RATINGS
IGC: Fundamental Ratings
IGC
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANVSIGC
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 26 days ago
83%
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Ad is loading...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QCRH66.931.03
+1.56%
QCR Holdings
GRMN190.611.65
+0.87%
Garmin Ltd
KFS8.090.04
+0.50%
Kingsway Financial Services
GPI391.38-1.32
-0.34%
Group 1 Automotive
CMMB1.12-0.04
-3.45%
Chemomab Therapeutics Ltd

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
-3.17%
ADXN - ANVS
41%
Loosely correlated
+0.94%
MDGL - ANVS
36%
Loosely correlated
-1.99%
EWTX - ANVS
33%
Poorly correlated
+3.22%
VTYX - ANVS
32%
Poorly correlated
+0.94%
AXON - ANVS
31%
Poorly correlated
-2.15%
More

IGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGC has been loosely correlated with TECX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if IGC jumps, then TECX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGC
1D Price
Change %
IGC100%
-0.53%
TECX - IGC
39%
Loosely correlated
-3.08%
ANVS - IGC
30%
Poorly correlated
-3.17%
AMLX - IGC
30%
Poorly correlated
+4.19%
LRMR - IGC
29%
Poorly correlated
+3.80%
VTGN - IGC
27%
Poorly correlated
+1.93%
More